Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of TAK-659 and Paclitaxel in Patients With Advanced Solid Tumors

NCT03756818 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03756818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03756818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of TAK-659 and Paclitaxel in Patients With Advanced Solid Tumors
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2019
Completion date
February 23, 2023
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, ovarian carcinoma, refractory malignant solid neoplasm, refractory ovarian carcinoma